Literature DB >> 27635156

Atypical presentation of sacrococcygeal yolk sac tumor in infant: beware of the injuries of the gluteal region.

Francesco Esposito1, Marco Di Serafino2, Patrizia Oresta1.   

Abstract

Malignant sacrococcygeal yolk sac tumor is a rare extra-gonadal germ cell tumor of infancy and childhood. We report the case of a 14-month-old white female infant with a rapidly growing supra-gluteal mass at first misdiagnosed as hemangioma after a clinical assessment. The lesion was then classified as extra-gonadal yolk sac tumor due to alarming ultrasound features, later confirmed at MRI and pathology. This report remarks the need of a rigorous methodology in the ultrasound exploration of the gluteal region.

Entities:  

Keywords:  Germ cell tumor; Sacrococcygeal region; Ultrasoud; Yolk sac tumor

Mesh:

Year:  2014        PMID: 27635156      PMCID: PMC5005202          DOI: 10.1007/s40477-014-0147-9

Source DB:  PubMed          Journal:  J Ultrasound        ISSN: 1876-7931


  5 in total

Review 1.  Pediatric presacral masses.

Authors:  Murat Kocaoglu; Donald P Frush
Journal:  Radiographics       Date:  2006 May-Jun       Impact factor: 5.333

2.  Sacrococcygeal teratoma: American Academy of Pediatrics Surgical Section Survey-1973.

Authors:  R P Altman; J G Randolph; J R Lilly
Journal:  J Pediatr Surg       Date:  1974-06       Impact factor: 2.545

3.  Sacrococcygeal yolk sac tumor presenting as subcutaneous fluid collection initially treated as abscess.

Authors:  Azher Merchant; Rosalyn W Stewart
Journal:  South Med J       Date:  2010-10       Impact factor: 0.954

4.  Extragonadal yolk sac tumor: sonographic and CT findings.

Authors:  M H Lev; J G Blickman
Journal:  AJR Am J Roentgenol       Date:  1993-02       Impact factor: 3.959

5.  A population-based analysis of 788 cases of yolk sac tumors: A comparison of males and females.

Authors:  Jay P Shah; Sanjeev Kumar; Christopher S Bryant; Rouba Ali-Fehmi; John M Malone; Gunter Deppe; Robert T Morris
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.